X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14323) 14323
Publication (1307) 1307
Book Review (379) 379
Book Chapter (241) 241
Reference (37) 37
Dissertation (24) 24
Conference Proceeding (19) 19
Magazine Article (11) 11
Book / eBook (8) 8
Data Set (4) 4
Government Document (4) 4
Web Resource (4) 4
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7725) 7725
serotonin reuptake inhibitors (5974) 5974
index medicus (5558) 5558
psychiatry (4936) 4936
male (4822) 4822
pharmacology & pharmacy (4464) 4464
female (4277) 4277
antidepressants (3554) 3554
animals (3180) 3180
neurosciences (3036) 3036
depression (3000) 3000
adult (2851) 2851
serotonin (2350) 2350
double-blind (2143) 2143
fluoxetine (2100) 2100
middle aged (2094) 2094
serotonin uptake inhibitors - therapeutic use (2029) 2029
antidepressive agents - therapeutic use (1852) 1852
clinical neurology (1787) 1787
selective serotonin reuptake inhibitors (1672) 1672
major depression (1653) 1653
rats (1551) 1551
treatment outcome (1468) 1468
aged (1373) 1373
major depressive disorder (1314) 1314
serotonin uptake inhibitors - adverse effects (1264) 1264
serotonin uptake inhibitors - pharmacology (1189) 1189
reuptake inhibitors (1152) 1152
adolescent (1149) 1149
paroxetine (1144) 1144
serotonin uptake inhibitors (1126) 1126
depressive disorder - drug therapy (1113) 1113
antidepressant (1069) 1069
dose-response relationship, drug (1047) 1047
depressive disorder, major - drug therapy (1045) 1045
antidepressive agents - adverse effects (1021) 1021
selective serotonin reuptake inhibitor (960) 960
efficacy (955) 955
placebo-controlled trial (949) 949
analysis (944) 944
obsessive-compulsive disorder (941) 941
drug therapy (917) 917
depression, mental (916) 916
pregnancy (909) 909
anxiety (887) 887
risk factors (880) 880
tricyclic antidepressants (870) 870
depression - drug therapy (855) 855
citalopram (806) 806
mice (799) 799
serotonin-reuptake inhibitors (797) 797
risk (793) 793
sertraline (792) 792
drugs (744) 744
double-blind method (725) 725
antidepressive agents - pharmacology (723) 723
research (712) 712
serotonin - metabolism (679) 679
rats, sprague-dawley (674) 674
care and treatment (661) 661
venlafaxine (642) 642
article (636) 636
medicine, general & internal (635) 635
drug interactions (634) 634
serotonin reuptake inhibitor (633) 633
medicine & public health (632) 632
metaanalysis (630) 630
brain (628) 628
young adult (618) 618
mental depression (617) 617
dopamine (601) 601
serotonin uptake inhibitors - administration & dosage (597) 597
fluvoxamine (591) 591
time factors (584) 584
child (560) 560
psychiatric status rating scales (554) 554
reuptake inhibitor (552) 552
children (541) 541
ssri (540) 540
pharmacotherapy (539) 539
placebo (538) 538
drug therapy, combination (535) 535
health aspects (527) 527
pharmacology (514) 514
psychology, clinical (513) 513
fluoxetine - pharmacology (512) 512
psychology (505) 505
comorbidity (490) 490
pharmacokinetics (485) 485
norepinephrine (483) 483
antidepressive agents, second-generation - therapeutic use (478) 478
prevalence (458) 458
disease models, animal (444) 444
phenols (442) 442
psychopharmacology (442) 442
mental disorders (438) 438
toxicology (435) 435
neurology (430) 430
rats, wistar (427) 427
brain - metabolism (425) 425
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13930) 13930
German (281) 281
French (158) 158
Japanese (73) 73
Spanish (68) 68
Italian (44) 44
Turkish (40) 40
Russian (30) 30
Portuguese (28) 28
Polish (18) 18
Korean (14) 14
Dutch (13) 13
Chinese (12) 12
Czech (8) 8
Danish (4) 4
Icelandic (4) 4
Hungarian (2) 2
Arabic (1) 1
Croatian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BBA - General Subjects, ISSN 0304-4165, 11/2017, Volume 1861, Issue 11, pp. 2766 - 2777
Journal Article
Journal Article
Analytical Biochemistry, ISSN 0003-2697, 06/2018, Volume 551, pp. 7 - 18
A simple and sensitive ultrasonic assisted magnetic dispersive solid phase microextraction method (UAMDSPME) coupled with high performance liquid... 
Serotonin–norepinephrine reuptake inhibitor drugs | Ultrasonic assisted magnetic dispersive solid phase microextraction | Experimental design | High performance liquid chromatography | Reduced graphene oxide Quantum Dots nanocomposites | PRECONCENTRATION | GRAPHENE OXIDE | CHEMISTRY, ANALYTICAL | HUMAN PLASMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | NANOMATERIALS | EMPLOYING EXPERIMENTAL-DESIGN | WATER SAMPLES PRIOR | GREEN | PERFORMANCE LIQUID-CHROMATOGRAPHY | EXTRACTION | NANOCOMPOSITE | Serotonin-norepinephrine reuptake inhibitor drugs | Duloxetine Hydrochloride - isolation & purification | Humans | Magnetics | Venlafaxine Hydrochloride - isolation & purification | Atomoxetine Hydrochloride - urine | Serotonin and Noradrenaline Reuptake Inhibitors - isolation & purification | Duloxetine Hydrochloride - urine | Nanocomposites - ultrastructure | Venlafaxine Hydrochloride - analysis | Water Wells | Atomoxetine Hydrochloride - isolation & purification | Serotonin and Noradrenaline Reuptake Inhibitors - urine | Limit of Detection | Microscopy, Electron, Scanning | Solid Phase Microextraction - statistics & numerical data | Serotonin and Noradrenaline Reuptake Inhibitors - analysis | Duloxetine Hydrochloride - analysis | Solid Phase Microextraction - methods | Atomoxetine Hydrochloride - analysis | Venlafaxine Hydrochloride - urine | Water Pollutants, Chemical - analysis | Ultrasonics | Quantum Dots - ultrastructure | Rivers - chemistry | Graphite | Water Supply
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 5/2014, Volume 28, Issue 5, pp. 403 - 439
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides... 
treatment | post-traumatic stress disorder | benzodiazepines | separation anxiety disorder | obsessive-compulsive disorder | anxiolytics | evidence-based guidelines | antidepressants | anxiety disorders | serotonin-noradrenaline reuptake inhibitor | Anticonvulsants | selective serotonin reuptake inhibitor | cognitive behaviour therapy | specific phobia | social anxiety disorder | antipsychotics | pregabalin | panic disorder | generalised anxiety disorder | RANDOMIZED CONTROLLED-TRIAL | CLINICAL NEUROLOGY | SEROTONIN REUPTAKE INHIBITORS | RESISTANT PANIC DISORDER | COGNITIVE-BEHAVIORAL THERAPY | PHARMACOLOGY & PHARMACY | PRIMARY-CARE PATIENTS | QUALITY-OF-LIFE | PSYCHIATRY | EVIDENCE-BASED PHARMACOTHERAPY | NEUROSCIENCES | VENLAFAXINE EXTENDED-RELEASE | PLACEBO-CONTROLLED TRIAL | LONG-TERM TREATMENT | Antidepressive Agents - therapeutic use | Decision Making | Evidence-Based Medicine - methods | Delivery of Health Care - methods | Obsessive-Compulsive Disorder - drug therapy | Stress Disorders, Post-Traumatic - drug therapy | Humans | Psychopharmacology - methods | Anxiety Disorders - drug therapy | Practice guidelines (Medicine) | Anxiety | Research | Drug therapy | Analysis | Post-traumatic stress disorder | Practice Guideline | Drug Therapy | Epidemiology | PTSD | Panic Disorder | Phobia | Anxiety Disorders | Treatment | Obsessive-Compulsive Disorder | Psychopharmacology | Evidence Based Treatment | Generalized Anxiety Disorder | Diagnosis
Journal Article